Full Name
Norma Echavarria
Company
Espacio TDAH
Job Title
CMA
Speaker Bio (200 words)
Norma C. Echavarría, MD, is a psychiatrist specializing in adult and child & adolescent psychiatry, with extensive clinical experience in the diagnosis and psychopharmacological treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) across the lifespan. She is an International Fellow of the American Psychiatric Association (APA) and serves as President of the ADHD Chapter of the Argentine Psychiatric Association (AAP).
Dr. Echavarría completed her medical degree with honors at the University of Buenos Aires and holds board certifications in Psychiatry, Child & Adolescent Psychiatry, and Legal Medicine. Her clinical background includes inpatient and outpatient psychiatric care in major public hospitals in Buenos Aires, as well as sustained private practice.
Her areas of specialization include ADHD in women and girls, late diagnosis in adulthood, psychiatric comorbidities, emotional dysregulation, and treatment adherence. She integrates evidence-based research with lifespan-sensitive clinical models and advocates for improved recognition of underdiagnosed ADHD presentations. She has presented internationally on impulsivity, suicide risk, stigma, and long-term treatment engagement in ADHD.
Dr. Echavarría completed her medical degree with honors at the University of Buenos Aires and holds board certifications in Psychiatry, Child & Adolescent Psychiatry, and Legal Medicine. Her clinical background includes inpatient and outpatient psychiatric care in major public hospitals in Buenos Aires, as well as sustained private practice.
Her areas of specialization include ADHD in women and girls, late diagnosis in adulthood, psychiatric comorbidities, emotional dysregulation, and treatment adherence. She integrates evidence-based research with lifespan-sensitive clinical models and advocates for improved recognition of underdiagnosed ADHD presentations. She has presented internationally on impulsivity, suicide risk, stigma, and long-term treatment engagement in ADHD.
Speaking At
